These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 2693444)
41. Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate. Lagacé-Wiens PR; Nichol KA; Nicolle LE; DeCorby M; McCracken M; Mulvey MR; Zhanel GG J Antimicrob Chemother; 2006 Jun; 57(6):1262-3. PubMed ID: 16565157 [No Abstract] [Full Text] [Related]
42. Incidence of beta-lactamase producing E. coli in urinary tract infections. Sami AA; Abd-el-Hamid T; Sabbour MS Chemioterapia; 1985 Dec; 4(6):429-30. PubMed ID: 3913532 [TBL] [Abstract][Full Text] [Related]
43. Sulfacytine vs. sulfisoxazole for urinary tract infections in an obstetric-gynecologic population. Jensen PA; Mueller JM Curr Ther Res Clin Exp; 1976 Jun; 19(6):573-8. PubMed ID: 819216 [No Abstract] [Full Text] [Related]
44. [Clinical and laboratory observations on the treatment of urinary infections with gentamicin]. Panero C; Acconcia A; Paolini R Minerva Med; 1967 Nov; 58(95 Suppl):4229-32. PubMed ID: 4866800 [No Abstract] [Full Text] [Related]
45. [Puerperal infection of the urinary tract]. Głab S; Idzik D; Kepa M; Sztaner M; Wróblewska I Pol Merkur Lekarski; 1996 Oct; 1(4):257-60. PubMed ID: 9156939 [TBL] [Abstract][Full Text] [Related]
46. Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli. Gagliotti C; Buttazzi R; Sforza S; Moro ML; J Infect; 2008 Sep; 57(3):179-84. PubMed ID: 18707763 [TBL] [Abstract][Full Text] [Related]
47. Urinary tract infections in 1- to 3-month-old infants: ambulatory treatment with intravenous antibiotics. Doré-Bergeron MJ; Gauthier M; Chevalier I; McManus B; Tapiero B; Lebrun S Pediatrics; 2009 Jul; 124(1):16-22. PubMed ID: 19564278 [TBL] [Abstract][Full Text] [Related]
49. Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern? Mangin D; Toop L; Chambers S; Ikram R; Harris B N Z Med J; 2005 Nov; 118(1225):U1726. PubMed ID: 16286940 [TBL] [Abstract][Full Text] [Related]
50. Sulphonamides in the treatment of acute Escherichia coli infection of the urinary tract in women. Clinical and ecological effects of sulphasomidine and sulphalene. Lidin-Janson G Scand J Infect Dis; 1977; 9(3):211-7. PubMed ID: 333556 [TBL] [Abstract][Full Text] [Related]
51. Susceptibility of Escherichia coli with capsular antigen K1 isolated from urinary tract infection on the joint action of cefotaxime and normal human serum. Jankowski S; Franiczek R Nephron; 1994; 68(4):519-20. PubMed ID: 7870242 [No Abstract] [Full Text] [Related]
52. Effects of a new combination of plant extracts plus d-mannose for the management of uncomplicated recurrent urinary tract infections. Genovese C; Davinelli S; Mangano K; Tempera G; Nicolosi D; Corsello S; Vergalito F; Tartaglia E; Scapagnini G; Di Marco R J Chemother; 2018 Apr; 30(2):107-114. PubMed ID: 29078739 [TBL] [Abstract][Full Text] [Related]
53. Treatment of the acute urethral syndrome. Stamm WE; Running K; McKevitt M; Counts GW; Turck M; Holmes KK N Engl J Med; 1981 Apr; 304(16):956-8. PubMed ID: 7010167 [No Abstract] [Full Text] [Related]